Community Member
12 days agoIs anyone else triple negative, BRCA2 positive metastatic, taking olaparib? I know it’s a new application for BRCA. Very hard to find anyone else who’s doing it.
Community Member
12 days agoFinding others with the same specific diagnosis and treatment combination can feel isolating, especially when dealing with a newer application of a medication. Connecting with others who share similar experiences often provides valuable insights and support, so hopefully some community members will share their experiences with olaparib for triple negative BRCA2 metastatic breast cancer.
Community Member
11 days agoI have been taking it for over a year with no evidence of disease
Community Member
11 days agoGosh, I’m glad to hear that. How are the side effects?
Community Member
11 days agoI was tired and nauseous for the first couple of months but taking zofran helped and continues to help today if needed. I did not have an appetite at the beginning so I did lose weight. I hope your journey is as positive as mine has been
Community Member
10 days agoYou’re a ray of sunshine, Theresa. My appetite is fine—craving sugar mostly. I assume that’s the fatigue talking. And I sleep a lot. Sending loads of positive energy.
Community Member
10 days agoI am glad to be of help. Best of luck
Community Member
6 days agoI am triple negative with PALB2 mutation. I started on Olaparib in Aug 2025. The results have been really positive. It seems to be regressing my cancer, which is in my bones and liver. I did have side effects for the first few months of severe gastrointestinal challenges. That has all gone away and my main side effect now is fatigue. I hope you have a positive journey.
Community Member
5 days agoThank you, Pat! That really gives me hope. I’ve only been on it for two weeks but my blood stats are already a little better and the pain is resolving. I’m afraid to get too pumped up (and too tired!) but hope is a wonderful thing. Sending lots of it to you.
New to the community?
Create an account to connect with others navigating cancer.
© 2026 Outcomes4Me Inc. All rights reserved.